A sponge you swallow could detect esophageal cancer before it spreads
NCT ID NCT05028725
First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time
Summary
This trial tests a new way to spot esophageal cancer early using a swallowable sponge called EsophaCap, which collects cells from the esophagus. A lab test then looks for DNA changes linked to cancer. The study enrolls adults with or suspected of having esophageal cancer, as well as healthy controls, to see how accurate the method is. If it works, it could lead to a simple, low-cost screening tool for high-risk areas.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a swallowable sponge (EsophaCap) and a DNA methylation biomarker test (EsoCAN assay)
- What this could lead to
- If successful, this could offer a simple, non-invasive screening method to catch esophageal cancer early, potentially saving lives in regions where the disease is common.
- What could go wrong
- This is an early-stage diagnostic study, not a treatment trial. The test may not be accurate enough in larger populations, and false positives or negatives could limit its usefulness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Muhimbili National Hospital (MNH)
RECRUITINGDar es Salaam, Mloganzila, Tanzania
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Muhimbili National Hospital (MNH)
RECRUITINGDar es Salaam, Upganda, Tanzania
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single Protein's mutations predict esophageal cancer outcomes?
- Could a genetic marker guide future cancer therapies in taiwan?
- Could a lighter immunotherapy schedule keep advanced cancers in check?
- New drug cocktail aims to shrink Hard-to-Treat esophageal tumors
- Smart T-Cell engager aims to outsmart tumors in first human test
- DNA clues may reveal which esophageal cancers will return soon after surgery